Meta-analysis outcomes
| Unruptured Aneurysms, (%) (95% CI) | I2 | Ruptured Aneurysms, (%) (95% CI) | I2 | All Aneurysms, (%) (95% CI) | I2 | |
|---|---|---|---|---|---|---|
| Complete angiographic occlusion | ||||||
| Initial | 85 (77–91) | 40 | 88 (79–93) | 71 | 85 (78–90) | 76 |
| Long-term | 90 (44–99) | 49 | 86 (80–90) | 45 | 91 (87–94) | 45 |
| Periprocedural outcomes | ||||||
| Rupture | 6 (0–13) | 0 | 9 (6–12) | 0 | 7 (5–9) | 0 |
| Thromboembolism | 4 (1–8) | NA | 4 (2–9) | 0 | 4 (3–6) | 0 |
| Morbidity | 2 (1–12) | NA | 3 (2–5) | 0 | 2 (2–4) | 0 |
| Mortality | 2 (1–13) | NA | 4 (2–7) | 0 | 3 (2–5) | 0 |
| Long-term favorable neurologic outcome | – | – | 74 (59–85) | NA | 79 (64–89) | 83 |
| Recanalization | – | – | 9 (5–17) | 28 | 6 (4–11) | 54 |
| Retreatment | – | – | 7 (3–14) | 12 | 7 (5–9) | 14 |
Note:—NA indicates not available.